心肌梗塞患者出血风险评估工具:比较综述和临床影响
Kaeshaelya Thiruchelvam1, Jonathan Than Chun Xin1, Win Kit Law1
1School of Pharmacy, IMU University, Bukit Jalil, Kuala Lumpur, Malaysia.
Expert review of cardiovascular therapy
|June 18, 2025
概括
流血风险分层工具对于治疗心肌梗塞 (MI) 患者至关重要. 本综述考察了既有和新兴的模型,强调了需要动态,综合的方法来改善患者的结果.
科学领域:
- 心脏病学 心脏病学
- 临床风险分层的临床风险分层
- 药物治疗 药物治疗
背景情况:
- 在最大限度地减少出血的同时优化缺血保护对于心肌梗塞 (MI) 患者至关重要,特别是那些接受双抗血小板治疗 (DAPT) 后皮肤冠状动脉干预 (PCI) 患者.
- 准确的出血风险分层对于指导治疗决策和改善患者在心脏病发作管理中的结果至关重要.
研究的目的:
- 审查和评估用于心肌梗塞 (MI) 管理的传统和新型出血风险分层模型.
- 确定当前模型的局限性,并建议未来的研究方向,以加强风险评估.
主要方法:
- 在PubMed,Scopus和Web of Science进行了系统的文献搜索,查找2005年1月至2024年12月期间发表的研究.
- 评估已建立的出血风险工具 (CRUSADE,AQUITY-HORIZONS,ACTION,PRECISE-DAPT) 和新兴的模型 (SWEDEHEART,ARC-HBR,CREDO-KYOTO,BleeMACS) 的使用情况.
主要成果:
- 既有工具预测了医院内和出院后的早期出血,但在长期评估和适应现代PCI方面存在局限性.
- 新兴模型包含更广泛的临床变量和长期预测因素,为当代MI管理提供了更好的适用性.
- 目前的模型显示中等的预测准确性 (c-统计0.70-0.80) 并依赖于静态因素,缺乏实时适用性和缺血风险的整合.
结论:
- 需要先进的出血风险模型,这些模型是动态的,整合了缺血风险,并在不同的人群中得到了验证.
- 未来的研究应该专注于人工智能驱动的模型和将其集成到电子健康记录中,以改善临床决策.
- 加强出血风险分层对于平衡抗血栓治疗和MI患者出血并发症至关重要.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
184
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
184
Acute Coronary Syndrome III: Diagnostic Studies
26
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
26
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
355
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
355
Acute Coronary Syndrome IV: Interprofessional Care
32
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
32
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
130
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
130


